Platelet-rich plasma as a scaffold for injectable soft-tissue augmentation

Cytotherapy

Volumn 12, Issue 5, 2010, Pages 701-702

  Wang, Ping ^a   Qu, Yili ^a   Man, Yi ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Anticoagulant; Growth factors; Platelet rich plasma; Soft tissue augmentation

Indexed keywords

GROWTH FACTOR; HEPARIN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; HUMAN; IMPLANTATION; PRIORITY JOURNAL; SOFT TISSUE AUGMENTATION; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; WOUND HEALING;

EID: 77956028812     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.487901     Document Type: Article

References (16)

1. Okabe K, Yamada Y, Ito K, Kohgo T, Yoshimi R, Ueda M. Injectable soft-tissue augmentation by tissue engineering and regenerative medicine with human mesenchymal stromal cells, platelet-rich plasma and hyaluronic acid scaffolds. Cytotherapy. 2009;11:307-316
2. Wu W, Chen F, Liu Y, Ma Q, Mao T. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model. J Oral Maxillofac Surg. 2007;65:1951-1957
3. Liu Y, Zhou Y, Feng H, Ma GE, Ni Y. Injectable tissueengineered bone composed of human adipose-derived stromal cells and platelet-rich plasma. Biomaterials. 2008;29: 3338-3345
4. Ueda M, Yamada Y, Kagami H, Hibi H. Injectable bone applied for ridge augmentation and dental implant placement: human progress study. Implant Dent. 2008;17:82-90.
5. Ito K, Yamada Y, Nagasaka T, Baba S, Ueda M. Osteogenic potential of injectable tissue-engineered bone: a comparison among autogenous bone, bone substitute (Bio-oss), plateletrich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings. J Biomed Mater Res A. 2005;73:63-72.
6. Cheng X, Lei D, Mao T, Yang S, Chen F, Wu W. Repair of critical bone defects with injectable platelet rich plasma/bone marrow-derived stromal cells composite: experimental study in rabbits. Ulus Travma Acil Cerrahi Derg. 2008;14:87-95.
7. Yamada Y, Ueda M, Naiki T, Nagasaka T. Tissue-engineered injectable bone regeneration for osseointegrated dental implants. Clin Oral Implants Res. 2004;15:589-597
8. Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng. 2004;10:955-964
9. Kazakos K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury. 2009;40:801-805
10. Blanton MW, Hadad I, Johnstone BH, Mund JA, Rogers PI, Eppley BL, et al. Adipose stromal cells and platelet-rich plasma therapies synergistically increase revascularization during wound healing. Plast Reconstr Surg. 2009;123:56S-64S.
11. Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft-tissue augmentation. Dermatol Surg. 2002;28: 491-494
12. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000; 26:135-137
13. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61:1303-1313
14. Intini G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials. 2009;30:4956-4966
15. G olanski J, Pietrucha T, Baj Z, Greger J, Watala C. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood: various anticoagulants are not equal. Thromb Res. 1996;83:199-216.
16. Lei H, Gui L, Xiao R. The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma. Clin Biochem. 2009;42:1452-1460